Peter DeLong
Impact in
- Virology top 5%
- HIV Research and Treatment
- Biotechnology top 5%
- Cancer Research and Treatments
Papers in
-
- Occupational and environmental lung diseases 4
- Oncology 7
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Steven Μ. Albelda (8 shared papers)Tomoyuki Tanaka (4 shared papers)Larry R. Kaiser (4 shared papers)Veena Kapoor (4 shared papers)Daniel H. Sterman (3 shared papers)Adam C. Henry (3 shared papers)Mamoru Watanabe (2 shared papers)Robert Kruklitis (4 shared papers)
- Journals
- Cancer Biology & Therapy (3 papers)Clinical Cancer Research (2 papers)Molecular Therapy (1 paper)Journal of Thoracic Oncology (1 paper)Nature (1 paper)
- Partner nations
- United StatesLebanonIndia
In The Last Decade
Peter DeLong
20 papers receiving 744 citations
Peers
Comparison fields: 5 of 76
- Virology 90
- Biotechnology 112
- Immunology 213
- Oncology 247
- Pulmonary and Respiratory Medicine 256
Countries citing papers authored by Peter DeLong
This map shows the geographic impact of Peter DeLong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter DeLong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter DeLong more than expected).
Fields of papers citing papers by Peter DeLong
This network shows the impact of papers produced by Peter DeLong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter DeLong. The network helps show where Peter DeLong may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter DeLong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 101 | |
| 2 | 2005 | 99 | |
| 3 | Use of cyclooxygenase-2 inhibition to enhance the efficacy of immunotherapy. | 2003 | 77 |
| 4 | 1989 | 71 | |
| 5 | 2003 | 69 | |
| 6 | 2003 | 65 | |
| 7 | 2004 | 51 | |
| 8 | 1990 | 49 | |
| 9 | 2004 | 42 | |
| 10 | 2002 | 37 | |
| 11 | 2005 | 25 | |
| 12 | 2006 | 18 | |
| 13 | 2011 | 14 | |
| 14 | 2003 | 13 | |
| 15 | 1999 | 12 | |
| 16 | 2011 | 11 | |
| 17 | 2016 | 9 | |
| 18 | 2000 | 5 | |
| 19 | 2007 | 1 | |
| 20 | 2021 | 1 |
About Peter DeLong
Peter DeLong is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Genetics and Immunology, having authored 20 papers that have together received 770 indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (4 papers), Virus-based gene therapy research (3 papers), Immune Cell Function and Interaction (3 papers), Inflammatory mediators and NSAID effects (3 papers), HIV Research and Treatment (2 papers), HIV/AIDS Research and Interventions (2 papers), Cancer Research and Treatments (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Virology (90 citations), Biotechnology (112 citations), Immunology (213 citations), Oncology (247 citations) and Pulmonary and Respiratory Medicine (256 citations). Peter DeLong has collaborated with scholars based in United States, Lebanon and India. Frequent co-authors include Steven Μ. Albelda, Tomoyuki Tanaka, Larry R. Kaiser, Veena Kapoor, Daniel H. Sterman, Adam C. Henry, Larry R. Kaiser, Mamoru Watanabe, Robert Kruklitis and Leslie A. Litzky. Their work appears in journals such as Cancer Biology & Therapy, Clinical Cancer Research, Molecular Therapy, Journal of Thoracic Oncology and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.